Physician profile
Stephen N Tafor
NPI 1700844321
$16,081.67
in general payments reported to CMS, 2019-2025
30 companies · $1,831 in 2025
The $1,831 reported for 2025 was more than what 76% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $933 · 2020: $740 · 2021: $1,146 · 2022: $1,779 · 2023: $5,723 · 2024: $3,929 · 2025: $1,831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,397 · Travel and Lodging: $4,034 · Education: $52.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,397.19 |
| Travel and Lodging | $4,034.40 |
| Education | $52.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,750.80 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Boston Scientific Corporation | $4,564.05 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Curonix LLC | $1,633.68 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Nalu Medical, INC. | $976.48 | 2022 | |
| Nevro Corp. | $928.84 | 2019-2024 | Senza |
| Surgentec | $610.33 | 2025 | Tilink, Ion |
| Collegium Pharmaceutical, INC. | $494.69 | 2021-2025 | Belbuca, Xtampza, Nucynta |
| Vertos Medical, INC. | $368.05 | 2023-2024 | Mild Device Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $253.63 | 2019-2025 | Relistor |
| Abbott Laboratories | $227.03 | 2021-2025 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $203.26 | 2019-2023 | Ztlido |
| Medtronic USA, INC. | $161.43 | 2019-2020 | |
| Spr Therapeutics, INC | $145.43 | 2021-2025 | Sprint Pns System |
| Flowonix Medical Incorporated | $124.60 | 2019-2020 | |
| Redhill Biopharma INC. | $110.04 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $87.93 | 2019-2021 | |
| Pfizer INC. | $74.54 | 2019-2020 | |
| Globus Medical, INC. | $54.48 | 2025 | Senza |
| Astrazeneca Pharmaceuticals Lp | $44.76 | 2019-2020 | |
| Grt US Holding, INC. | $40.55 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $36.87 | 2019 | |
| Forte Bio-Pharma LLC | $34.95 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Shionogi INC | $30.66 | 2019 | |
| Mdd US Operations, LLC | $20.25 | 2019 | |
| Horizon Therapeutics Plc | $19.72 | 2023 | Krystexxa |
| Arbor Pharmaceuticals, INC. | $18.66 | 2019 | |
| Orthogenrx INC. | $17.52 | 2020 | |
| Painteq LLC | $17.12 | 2023 | Painteq |
| Eisai INC. | $15.92 | 2020 | |
| Elutia, INC. | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Tafor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.